Market revenue in 2023 | USD 1,071.6 million |
Market revenue in 2030 | USD 1,486.1 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Percutaneous thrombectomy devices |
Fastest growing segment | Neurovascular Embolectomy Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Embolectomy Devices, Embolectomy Balloon Catheters, Percutaneous Thrombectomy Devices, Catheter-directed thrombolysis (CDT) devices, Inferior vena cava filters (IVCF) |
Key market players worldwide | Medtronic PLC, Boston Scientific Corp, Teleflex Inc, Edwards Lifesciences Corp, LeMaitre Vascular Inc, Cook Medical, DePuy Synthes, iVascular, Vascular Solutions |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clot management devices market will help companies and investors design strategic landscapes.
Percutaneous thrombectomy devices was the largest segment with a revenue share of 36.16% in 2023. Horizon Databook has segmented the North America clot management devices market based on neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (cdt) devices, inferior vena cava filters (ivcf) covering the revenue growth of each sub-segment from 2018 to 2030.
The growing geriatric population in developed economies, such as the U.S. and Canada, is expected to drive the regional market during the forecast period. According to the American Society of Hematology, the geriatric population is at an increased risk of developing clots.
Moreover, the incidence of Venous Thromboembolism (VTE) significantly increases after 60 years, with 1 in 1,000 people diagnosed with VTE, which is approximately 1000x higher than those aged 45 or younger.
Furthermore, the growing incidence of high blood pressure & cholesterol in the adult population is driving the clot management devices market growth. High blood pressure damages the artery walls, thereby making them likely to form plaque deposits & clots.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America clot management devices market , including forecasts for subscribers. This continent databook contains high-level insights into North America clot management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account